Other grades of this product :
| Teduglutide Basic information |
| Product Name: | Teduglutide | | Synonyms: | ALX 0600;Gattex;Glucagon-like peptide II [2-glycine] (human);Teduglutide;ALX 0600 USP/EP/BP;TIANFU 197922-42-2 Teduglutide;Teduglutide(ALX-0600);Revestive | | CAS: | 197922-42-2 | | MF: | C164H252N44O55S | | MW: | 3752.08248 | | EINECS: | | Product Categories: | | Mol File: | 197922-42-2.mol |
| Teduglutide Chemical Properties |
| Teduglutide Usage And Synthesis |
| Description | Teduglutide was approved in August 2012 by the European Commission and in December 2012 by the US FDA for the treatment of adults with short bowel syndrome (SBS) who are dependent on parenteral nutrition (PN). Teduglutide (also known as ALX-0600) is a GLP-2 analogue in which glycine has been substituted for alanine at position 2 from the N-terminus, thereby conferring resistance to degradation by DPP-4. Teduglutide has similar binding affinity, agonist potency, and agonist efficacy as GLP-2 in assays with the rat GLP-2 receptor. Administration of teduglutide to rats gave a significant increase in small intestine weight and an increase in the height of intestinal villi. Teduglutide was prepared by solid-phase peptide synthesis. | | Originator | NPS Allelix (Canada) | | Uses | Treatment
of intestinal diseases characterized by chemical or
surgical damage of the intestinal epithelium such as Short
Bowel Syndrome (SBS) or damage to the intestinal
epithelium due to disease (glucagon-like peptide-2 (GLP-
2) analog). | | Definition | ChEBI: A 33-membered polypeptide consisting of His, Gly, Asp, Gly, Ser, Phe, Ser, Asp, Glu, Met, Asn, Thr, Ile, Leu, Asp, Asn, Leu, Ala, Ala, Arg, Asp, Phe, Ile, Asn, Trp, Leu, Ile, Gln, Thr, Lys, Ile, Thr and Asp residues joined in sequence. A glucagon-like pep
ide-2 receptor agonist used for the treatment of short-bowel syndrome. | | Application | Teduglutide is a peptide hormone that is used to treat pediatric patients with long-term efficacy. It has been shown to be effective in the treatment of autoimmune diseases and bowel disease. It is a long-acting analogue of glucagon-like peptide 1 (GLP-1). The drug has been shown to have high chemical stability, which means it does not break down easily. Teduglutide is injected into the body and taken up by cells, where it activates receptors on the surface of cells. This activation leads to increased glucose production by the liver and improved insulin sensitivity in peripheral tissues such as muscle, fat, and liver. It also increases heart rate and blood pressure. | | Brand name | Gattex | | Clinical Use | Human glucagon-like peptide-2 (GLP-2):
Treatment of short bowel syndrome | | Drug interactions | Potentially hazardous interactions with other drugs
Potential for increased absorption of some
medications. Monitor narrow therapeutic index
drugs carefully. | | Metabolism | The metabolism of teduglutide is not fully known. Since
teduglutide is a peptide it is likely that it follows the
principal mechanism for peptide metabolism.
See 'Other information'. |
| Teduglutide Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye